Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 13, 271 (1 March 2007) | doi:10.1038/nm0307-271b;
Spotlight on... Ken Duncan
Abstract
Ken Duncan began the year with a new job to fight an old foe. In January, he became a senior program officer for the Bill & Melinda Gates Foundation's tuberculosis (TB) program, where his job will be to shepherd the development of new drugs for the disease.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
